Ancestry-restricted expression of P2RX5 defines a CAR T-cell target across diverse blood cancers
Preprint
Abstract
Purinergic receptor P2RX5 can serve as an HLA-restricted graft-versus-leukemia antigen 1 . Yet, its direct targeting with chimeric antigen receptor (CAR) T cells remains unexplored, due to the prevailing view that protein-truncating mutations have rendered human P2RX5 a pseudogene 2 . Here, leveraging transcriptomic datasets and newly-developed monoclonal antibodies, we show that up to 75% of individuals with African ancestry express the full-length variant of P2RX5 (P2RX5-FL). While in healthy tissues P2RX5 is transcribed only in B cells and prenatal thymocytes, it is upregulated across multiple hematologic cancers including B-cell lymphomas (BCL), multiple myelomas (MM), and T-cell acute lymphoblastic leukemias (T-ALL). Crucially, unlike its truncated counterparts, P2RX5-FL protein is stable and plasma membrane-bound. We reformatted one monoclonal antibody as a P2RX5-directed CAR and expressed it in donor T cells. These CART-X5 cells were not prone to fratricide and were effective in reducing disease burden and extending survival in xenograft mouse models of T-ALL and MM. Together, these findings nominate P2RX5-FL as an immunotherapy target for BCL and MM patients that have relapsed after CD19 or BCMA-directed therapies with antigen-negative disease 3–6 . P2RX5-FL could also be targeted in chemoresistant T-ALL, where new immunotherapies avoiding CAR T-cell fratricide and T-cell aplasia are urgently needed 7,8 .Keywords
This publication has 132 references indexed in Scilit:
- Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myelomaCancer Cell, 2025
- Access and outcomes of racial and ethnic minority populations receiving commercial anti-BCMA CART for myelomaBlood Immunology & Cellular Therapy, 2025
- EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsCancer Cell, 2025
- Rehabilitation of the P2X5 receptor: a re-evaluation of structure and functionPurinergic Signalling, 2022
- Genome‐defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B‐cell lymphomaCancer, 2020
- RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell TypesCell Reports, 2019
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 PatientsCancer Cell, 2018
- On Essentiality and the World Health Organization's Model List of Essential MedicinesAnnals of Global Health, 2017
- Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemiaCancer, 2013
- Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysisCancer Immunology, Immunotherapy, 2009